TMDX Income Statement - TTM - TransMedics Group, Inc.

Income Statement (TTM)

TransMedics Group, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	24	26	25	30	28	30	39	51	72	93	119	151	192	242	297	359	401	442	488	531
Change (%)		6.52	-1.86	19.00	-5.75	7.23	29.17	31.59	39.49	30.25	27.47	26.81	26.97	25.96	22.89	20.83	11.80	10.09	10.57	8.82
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	9	9	9	10	9	9	11	14	20	28	37	47	65	88	112	141	163	179	198	214
Change (%)		5.67	-4.75	12.83	-4.71	-1.27	16.85	33.74	41.97	39.56	31.97	25.68	38.93	34.76	27.53	26.27	15.71	10.03	10.26	7.95
% of Revenue	35.40	35.12	34.08	32.32	32.67	30.08	27.21	27.66	28.15	30.16	31.22	30.95	33.86	36.23	37.60	39.29	40.66	40.64	40.53	40.21

Gross Operating Profit	16	17	17	20	19	21	28	37	52	65	82	104	127	154	185	218	238	262	290	318
Change (%)		6.99	-0.29	22.19	-6.24	11.36	34.47	30.79	38.54	26.61	25.53	27.33	21.61	21.46	20.24	17.55	9.27	10.12	10.79	9.41
% of Revenue	64.60	64.88	65.92	67.68	67.33	69.92	72.79	72.34	71.85	69.84	68.78	69.05	66.14	63.77	62.40	60.71	59.34	59.36	59.47	59.79

SG&A	24	24	24	28	32	38	45	54	60	70	81	93	107	118	129	142	154	169	176	177
Change (%)		0.01	0.55	13.55	17.53	17.94	18.68	18.09	12.14	16.16	15.80	14.79	14.85	10.15	9.51	10.52	8.44	9.30	4.43	0.68
% of Revenue	100.48	94.34	96.66	92.23	115.02	126.51	116.24	104.31	83.86	74.79	67.94	61.50	55.63	48.65	43.36	39.66	38.46	38.19	36.07	33.37

R&D	21	19	17	20	21	22	25	26	27	27	25	27	31	36	42	47	50	56	62	64
Change (%)		-8.34	-8.99	13.96	5.16	8.60	13.46	1.66	6.39	-2.04	-6.20	6.27	16.18	16.12	15.28	13.39	6.65	11.35	10.33	3.36
% of Revenue	85.36	73.45	68.11	65.23	72.78	73.70	64.74	50.01	38.15	28.69	21.11	17.69	16.19	14.92	14.00	13.14	12.53	12.68	12.65	12.01

OpEx	53	52	50	57	62	70	81	94	108	125	143	166	203	241	282	330	368	404	436	455
Change (%)		-2.31	-3.82	13.56	9.49	12.01	16.77	15.02	15.10	15.93	14.73	16.12	21.83	18.95	16.91	17.18	11.29	9.90	7.84	4.36
% of Revenue	221.24	202.91	198.86	189.78	220.46	230.29	208.19	181.97	150.15	133.64	120.28	110.14	105.68	99.80	94.95	92.08	91.66	91.51	89.24	85.59

Operating Income	-29	-26	-25	-27	-34	-39	-42	-42	-36	-31	-24	-15	-11	0	15	28	33	37	53	77
Change (%)		-9.59	-5.72	8.07	26.47	15.98	7.26	-0.29	-14.66	-12.64	-23.16	-36.59	-28.86	-104.45	2,991.75	89.46	17.76	12.08	40.06	45.81
% of Revenue	-121.24	-102.91	-98.86	-89.78	-120.46	-130.29	-108.19	-81.97	-50.15	-33.64	-20.28	-10.14	-5.68	0.20	5.05	7.92	8.34	8.49	10.76	14.41

Interest Expense	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-4	-5	-8	-11	-13	-14	-14	-14	-14	-14
Change (%)		-2.26	-2.26	-0.92	0.21	0.18	0.21	0.18	-4.94	0.78	3.52	39.75	52.00	31.71	23.23	8.41	0.19	-0.24	-0.95	-1.03
% of Revenue	-16.94	-15.54	-15.48	-12.89	-13.70	-12.80	-9.93	-7.56	-5.15	-3.99	-3.24	-3.57	-4.27	-4.47	-4.48	-4.02	-3.60	-3.26	-2.92	-2.66

Net Income	-32	-29	-28	-30	-38	-44	-47	-48	-42	-36	-28	-18	-36	-25	-10	3	33	35	49	72
Change (%)		-9.07	-3.25	7.81	26.26	16.79	5.98	1.82	-11.60	-14.10	-21.88	-37.17	101.20	-30.05	-59.27	-129.43	987.93	8.66	38.02	46.40
% of Revenue	-131.35	-112.13	-110.54	-100.14	-134.15	-146.11	-119.88	-92.76	-58.78	-38.77	-23.76	-11.77	-18.65	-10.36	-3.43	0.84	8.14	8.03	10.03	13.49

Source: Capital IQ

DE:8T8
US:TMDX	$107.79
IT:1TMDX	€103.10

TransMedics Group, Inc. - Income Statement (TTM)

Income Statement (TTM)

Other Listings